Evidence map›Paper›PMID 36827605›Full record

ArticleBrain pathology (Zurich, Switzerland)2023

Correspondence comprehensive characterization of a brainstem aggregoma (light and heavy chain deposition disease).

Aline P Becker, Diana S Osorio, Erica H Bell, Pierre Giglio, Jessica L Fleming, Catherine E Cottrell, Elaine R Mardis, Katherine E Miller, Kathleen M Schieffer, Benjamin J Kelly and 7 more

Abstract readLetter
PubMed Full text at PMC Publisher
In one paragraph

Article in Brain pathology (Zurich, Switzerland), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors.

Aline P BeckerDepartment of Radiation Oncology, The Ohio State University, Columbus, Ohio, USA.ORCID 0000-0002-8695-810X
Diana S OsorioDepartment of Pediatric Neuro-Oncology, Nationwide Children's Hospital, Columbus, Ohio, USA.
Erica H BellDepartment of Radiation Oncology, The Ohio State University, Columbus, Ohio, USA.
Pierre GiglioDepartment of Neurology, The Ohio State University, Columbus, Ohio, USA.
Jessica L FlemingDepartment of Radiation Oncology, The Ohio State University, Columbus, Ohio, USA.
Catherine E CottrellThe Steve and Cindy Rasmussen Institute for Genomic Medicine, Nationwide Children's Hospital, Columbus, Ohio, USA.
Elaine R MardisThe Steve and Cindy Rasmussen Institute for Genomic Medicine, Nationwide Children's Hospital, Columbus, Ohio, USA.
Katherine E MillerThe Steve and Cindy Rasmussen Institute for Genomic Medicine, Nationwide Children's Hospital, Columbus, Ohio, USA.
Kathleen M SchiefferThe Steve and Cindy Rasmussen Institute for Genomic Medicine, Nationwide Children's Hospital, Columbus, Ohio, USA.
Benjamin J KellyThe Steve and Cindy Rasmussen Institute for Genomic Medicine, Nationwide Children's Hospital, Columbus, Ohio, USA.
Mina S MakaryDepartment of Radiology, The Ohio State University, Columbus, Ohio, USA.
Wayne SloneDepartment of Radiology, The Ohio State University, Columbus, Ohio, USA.
Don BensonDepartment of Hematology, The Ohio State University, Columbus, Ohio, USA.
Jeffrey LeonardDepartment of Neurosurgery, Nationwide Children's Hospital, Columbus, Ohio, USA.
Samir B KahwashDepartment of Pathology, The Ohio State University, Columbus, Ohio, USA.
Daniel R BouéDepartment of Pathology, The Ohio State University, Columbus, Ohio, USA.
Arnab ChakravartiDepartment of Radiation Oncology, The Ohio State University, Columbus, Ohio, USA.ORCID 0000-0002-5392-8721

Funding

OSU as Network Lead Academic Participating Site for the NCI NCTNU10CA180850 · NCI · OHIO STATE UNIVERSITY · PI BLUM, KRISTIE A, CHAKRAVARTI, ARNAB · 2014 to 2018
$6.8M
Signal Transduction Pathways in GlioblastomaR01CA108633 · NCI · OHIO STATE UNIVERSITY · PI CHAKRAVARTI, ARNAB · 2005 to 2009
$2.3M
TOWARDS A REFINED MOLECULAR RECURSIVE PARTITIONING ANALYSIS MODEL FOR GLIOBLASTOMRC2CA148190 · NCI · AMERICAN COLLEGE OF RADIOLOGY · PI ALDAPE, KENNETH D, CHAKRAVARTI, ARNAB · 2009 to 2010
$2.1M
Therapeutic Exploitation of Mutant BRAF for AstrocytomaR01CA169368 · NCI · UNIVERSITY OF TEXAS HLTH SCIENCE CENTER · PI HOUGHTON, PETER J · 2013 to 2017
$1.6M
NCI NIH HHS R01 CA108633NCI NIH HHS R01 CA169368NCI NIH HHS RC2 CA148190NCI NIH HHS U10 CA180850
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

ParaproteinemiasBrain StemHumansImmunoglobulin Light ChainsImmunoglobulin Light Chainsaggregomagenomic profilingimmunoglobulin kappa-chainslight and heavy chain deposition diseasemass spectrometry

Identifiers

PMID36827605
PMCPMC10467036

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.